Director, Clinical Program Management

Provide strategic and operational leadership for the planning, management, oversight, and execution of clinical programs in support of Alkermes’ R&D portfolio. This role is accountable for advancing programs across the development lifecycle, including lifecycle management (LCM) initiatives and supplemental NDA (sNDA) submissions, with a focus on high-quality, patient-centric execution.

Alkermes has recently adopted a hybrid working environment to support and meet the needs of employees and this role will operate in a flexible environment with 60% of time in the office and 40% from home. This position is eligible for the hybrid workplace model, requiring work to be completed onsite at our Waltham, MA office at least 3 days per week. This role is not eligible for fully remote work.

Responsible for planning, oversight and execution of assigned clinical programs: responsible for timelines, budget, and key deliverables as well as contributing to overall clinical strategy

Participates on Clinical Teams as operational representative, partnering closely with Clinical Science, Biostatistics, Regulatory, Medical Affairs, Translational Medicine, and other functions to shape and execute integrated clinical development plan

Responsible for project budget/resource planning, re-forecasting, milestone, payment and variance tracking with Clinical Outsourcing & Finance, and Project Management.

Establish and monitor program performance metrics, leveraging data and insights to continuously improve execution and inform leadership decision-making.

Provides strategic input and oversight in development of clinical plans, protocols, SAPs, consent form development, and other program/study related documents.

Works with clinical outsourcing, legal, and finance in the selection of CROs and vendors, and participates in contract and budget negotiations.

Manages relationships and establishes strong partnerships with CROs, vendors, investigators and other external partners to ensure delivery of high-quality, timely outcomes.

Partner with the Study Start-Up team on clinical start-up activities including feasibility, country selection/recommendation, budget & timeline planning, supply chain, and regulatory preparation.

Provides oversight for project-related data integration/technology activities including IVRS, ePRO, central lab, etc along with data management department.

Provides oversight and support to direct reports fostering talent development, performance management, and a culture aligned with Alkermes leadership expectations and values.

Basic Qualifications:

Bachelor’s Degree in life sciences or healthcare-related field; Master’s Degree preferred.

Minimum of 10 years of clinical development experience in a pharmaceutical/biotech or CRO setting.

Preferred Qualifications:

Proven track record of leading global, complex clinical programs across multiple phases, with deep experience in Phase 4/LCM programs

Strong leadership presence with the ability to influence and drive alignment across cross-functional teams.

Excellent strategic thinking, organizational, and execution skills with the ability to manage competing priorities.

Strong knowledge and understanding of GCP/ICH Guidelines and regulatory requirements.

Physical Demands and Work Environment:

Ability to travel domestically and internationally (up to 20%)

The annual base salary for this position ranges from $219,626 to $235,120. In addition, this position is eligible for an annual performance pay bonus. Exact compensation may vary based on skills, training, knowledge, and experience. Alkermes offers a competitive benefits package. Additional details can be found on our careers website: www.alkermes.com/careers#working-here

#LI-HB1

Why join Team Alkermes?

Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.

We are proud to have been recognized as an employer of choice by many national organizations. In 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts’ Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine.

Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.